Unlocking AI in medical affairs
What every medical affairs leader needs to know about generative AI in pharma
Join us for an insight-packed discussion on: “What every medical affairs leader needs to know about generative AI in pharma,” featuring healthcare experts Rob Stevens and Zayed Yasin, MD.
Discover the current state of generative AI in medical affairs, explore real-world applications, and get practical advice based on decades of combined experience at firms including Novartis and Pfizer.
What you'll learn:
| Industry perspective on the current state of generative AI in pharma, particularly in medical affairs | |
| Practical ways to use generative AI in medical affairs today | |
| Critical considerations such as challenges, risks, and legal/ regulatory constraints involved. |
Who should attend:
| Leaders in medical affairs and commercial groups at pharma companies | |
| Pharma tech and IT leaders |